Co-Delivery Anticancer Drug Nanoparticles for Synergistic Therapy Against Lung Cancer Cells

Strategies to overcome acquired resistance to EGFR TKI in the treatment of non-small cell lung cancer

(2019) J. Gao et al.   Clinical & Translational Oncology

Overcoming acquired resistance of gefitinib in lung cancer cells without T790M by AZD9291 or Twist1 knockdown in vitro and in vivo

(2019) Zhongwei Liu et al.   ARCHIVES OF TOXICOLOGY

Synergistic effect of PLGA nanoparticles and submicron triglyceride droplets in enhancing the intestinal solubilisation of a lipophilic weak base

(2018) Paul Joyce et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Management of acquired resistance to EGFR TKI–targeted therapy in advanced non-small cell lung cancer

(2018) Shang-Gin Wu et al.   Molecular Cancer

PLGA Nanoparticles and Polysorbate-80-Coated PLGA Nanoparticles Increase the In vitro Antioxidant Activity of Melatonin

(2018) Leiziani Gnatkowski Martins et al.   Current Drug Delivery

Purification of Drug Loaded PLGA Nanoparticles Prepared by Emulsification Solvent Evaporation Using Stirred Cell Ultrafiltration Technique

(2017) Suresh K. Paswan et al.   PHARMACEUTICAL RESEARCH

Antitumor activity of high-dose pulsatile gefitinib in non-small-cell lung cancer with acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors

(2017) Yitao Wan et al.   Experimental and Therapeutic Medicine

PLGA-Based Nanoparticles as Cancer Drug Delivery Systems

(2014) Fatemeh Sadat Tabatabaei Mirakabad et al.   Asian Pacific Journal of Cancer Prevention

Quercetin-Loaded Microcapsules Ameliorate Experimental Colitis in Mice by Anti-inflammatory and Antioxidant Mechanisms

(2013) Carla F. S. Guazelli et al.   JOURNAL OF NATURAL PRODUCTS

Quercetin liposomes protect against radiation-induced pulmonary injury in a murine model

(2013) HAO LIU et al.   Oncology Letters

Drug Absorption Interactions Between Oral Targeted Anticancer Agents and PPIs: Is pH-Dependent Solubility the Achilles Heel of Targeted Therapy?

(2012) N R Budha et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Quercetin enhances the effects of 5-fluorouracil-mediated growth inhibition and apoptosis of esophageal cancer cells by inhibiting NF-κB

(2012) LU CHUANG-XIN et al.   Oncology Letters

Oral bioavailability of quercetin from different quercetin glycosides in dogs

(2010) Marianne Reinboth et al.   BRITISH JOURNAL OF NUTRITION

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER